Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Vaccine Immune Response”

1,271 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 1,271 results

Testing effectiveness (Phase 2)Study completedNCT00111579
What this trial is testing

Study to Evaluate the Immune Responses of Trivalent Cold-Adapted Influenza Vaccine (CAIV-T) Compared With (TIV)

Who this might be right for
Influenza
MedImmune LLC 52
Post-approval studies (Phase 4)Study completedNCT01827462
What this trial is testing

Comparison of Immune Responses to Influenza Vaccine In Adults of Different Ages (SLVP015 2007-2017)

Who this might be right for
Influenza
Stanford University 136
Not applicableStudy completedNCT01472627
What this trial is testing

Effects of Bortezomib-Based Therapy on Cellular Immunity and Response to DC/Myeloma Fusion Vaccines in Vitro

Who this might be right for
Multiple Myeloma
Dana-Farber Cancer Institute 11
Not applicableStudy completedNCT02915861
What this trial is testing

Eschar Investigations in Scrub Typhus

Who this might be right for
Scrub Typhus
University of Oxford 44
Testing effectiveness (Phase 2)Study completedNCT02956837
What this trial is testing

Rank Different Dosages of Antigen of GlaxoSmithKline (GSK) Biologicals' Investigational Respiratory Syncytial Virus (RSV) Vaccine (GSK3003891A), Based on Their Immune Response and Safety, When Administered to Healthy Adult Women

Who this might be right for
Respiratory Syncytial Virus Infections
GlaxoSmithKline 406
Not applicableStudy completedNCT04222595
What this trial is testing

FluPRINT Study: Characterisation of the Immune and Transcriptional Response to LAIV

Who this might be right for
Immunization
University of Oxford 33
Not applicableLooking for participantsNCT07047053
What this trial is testing

Evaluation of the Anti-VZV Vaccine Response of Patients With Immune-mediated Systemic Inflammatory Diseases Vaccinated in the Care Setting

Who this might be right for
Vaccination Varicella-zoster VirusImmune-mediated Systemic Inflammatory Diseases
Assistance Publique - Hôpitaux de Paris 50
Not applicableStudy completedNCT06041867
What this trial is testing

Agaricus Bisporus and Influenza Vaccination Response

Who this might be right for
Immune Response
Maastricht University Medical Center 88
Testing effectiveness (Phase 2)Study completedNCT00353977
What this trial is testing

Accelerated Immunization to Induce Cytomegalovirus Immunity in Stem Cell Donors

Who this might be right for
Cytomegalovirus Infections
National Heart, Lung, and Blood Institute (NHLBI) 38
Early research (Phase 1)Study completedNCT04851977
What this trial is testing

A First in Human Study to Evaluate the Safety and Immune Response to a Vaccine for the Treatment of a Respiratory Virus, When Administered Into the Arm in Healthy Adult Participants

Who this might be right for
Respiratory Syncytial Virus Infections
Advaccine (Suzhou) Biopharmaceuticals Co., Ltd. 60
Very early researchUnknownNCT04726553
What this trial is testing

Nature of Anifrolumab Impact on Vaccine-Emergent Immunity in SLE

Who this might be right for
Systemic Lupus Erythematosus (SLE)
Oklahoma Medical Research Foundation 20
Large-scale testing (Phase 3)Study completedNCT00518180
What this trial is testing

Evaluate Safety and Immune Response of Novartis Meningococcal ACWY Conjugate Vaccine In Adolescents

Who this might be right for
Meningococcal MeningitisHuman Papillomavirus InfectionPertussis+1 more
Novartis Vaccines 1,620
Testing effectiveness (Phase 2)Ended earlyNCT04276896
What this trial is testing

Immunity and Safety of Covid-19 Synthetic Minigene Vaccine

Who this might be right for
Pathogen Infection Covid-19 Infection
Shenzhen Geno-Immune Medical Institute 100
Large-scale testing (Phase 3)Ended earlyNCT06705140
What this trial is testing

A Study on the Immunogenicity and Safety of 3 Different Dose Concentrations of a Respiratory Syncytial Virus Vaccine in Infants and Toddlers

Who this might be right for
RSV ImmunisationHealthy Volunteers
Sanofi Pasteur, a Sanofi Company 42
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06919796
What this trial is testing

MRNA Covid-19 Vaccine Immune Response Comparisons Using Different Delivery Routes

Who this might be right for
Evaluate Immune Responses Following mRNA COVID-19 Vaccine Administration Through Different Delivery Routes in Healthy VolunteersSARS CoV-2
PharmaJet, Inc. 40
Post-approval studies (Phase 4)Study completedNCT00133510
What this trial is testing

Influenza Vaccine in Pediatric Transplant Subjects

Who this might be right for
Influenza
National Institute of Allergy and Infectious Diseases (NIAID) 60
Early research (Phase 1)Study completedNCT00920517
What this trial is testing

Safety and Immune Response to Two Doses of rDEN2/4delta30 Dengue Vaccine

Who this might be right for
Dengue Fever
National Institute of Allergy and Infectious Diseases (NIAID) 25
Not applicableStudy completedNCT01288950
What this trial is testing

Vitamin D Supplementation Enhances Immune Response to Bacille-Calmette-Guerin (BCG) Vaccination in Infants

Who this might be right for
Tuberculosis
University of California, San Diego 49
Post-approval studies (Phase 4)Study completedNCT02101749
What this trial is testing

Immune Response of Intradermal and Intramuscular Preparations of Inactive Seasonal Influenza Vaccine in Older Age Group.

Who this might be right for
Influenza, Human
Mahidol University 221
Early research (Phase 1)Study completedNCT05968989
What this trial is testing

Trial to Evaluate the Safety, Tolerability, and Immunogenicity of a Mosaic Hexavalent Influenza Vaccine VRC-FLUMOS0116-00-VP (FluMos-v2) in Healthy Adults

Who this might be right for
Influenza
National Institute of Allergy and Infectious Diseases (NIAID) 30
Next Page